Science and Research

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development

Bronchopulmonary dysplasia is a chronic lung disease of preterm infants. It is caused by the disturbance of physiologic lung development mainly in the saccular stage with lifelong restrictions of pulmonary function and an increased risk of abnormal somatic and psychomotor development. The contributors to this disease's entity are multifactorial with pre- and postnatal origin. Central to the pathogenesis of bronchopulmonary is the induction of a massive pulmonary inflammatory response due to mechanical ventilation and oxygen toxicity. The extent of the pro-inflammatory reaction and the disturbance of further alveolar growth and vasculogenesis vary largely and can be modified by prenatal infections, antenatal steroids, and surfactant application.This minireview summarizes the important recent research findings on the pulmonary inflammatory reaction obtained in patient cohorts and in experimental models. Unfortunately, recent changes in clinical practice based on these findings had only limited impact on the incidence of bronchopulmonary dysplasia.

  • Shahzad, T.; Radajewski, S.; Chao, C. M.; Bellusci, S.; Ehrhardt, H.

Keywords

  • Alveologenesis
  • Antenatal steroids
  • Apoptosis
  • Bronchopulmonary dysplasia
  • Chronic lung disease of the preterm infant
  • Infection
  • Inflammation
  • Lung development
  • Surfactant
  • Vasculogenesis
Publication details
DOI: 10.1186/s40348-016-0051-9
Journal: Molecular and cellular pediatrics
Pages: 23 
Number: 1
Work Type: Review
Location: UGMLC
Disease Area: PALI, DPLD
Partner / Member: JLU
Access-Number: 27357257
See publication on PubMed

DZL Engagements

chevron-down